9 METERS BIOPHARMA, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
9 Meters Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2022.
  • 9 Meters Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $42.6M, a 27.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $42.6M +$9.14M +27.3% Dec 31, 2022 10-K 2023-03-28
Q4 2021 $33.5M +$6.38M +23.5% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $27.1M +$11.7M +75.9% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $15.4M +$6.62M +75.5% Dec 31, 2019 10-K 2021-03-22
Q4 2018 $8.77M +$4.92M +128% Dec 31, 2018 10-K 2020-03-20
Q4 2017 $3.85M -$8.16M -67.9% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $12M +$2.07M +20.9% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $9.94M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.